133 related articles for article (PubMed ID: 23481651)
1. Demonstration of a sucrose-derived contrast agent for magnetic resonance imaging of the GI tract.
Martinez GV; Navath S; Sewda K; Rao V; Foroutan P; Alleti R; Moberg VE; Ahad AM; Coppola D; Lloyd MC; Gillies RJ; Morse DL; Mash EA
Bioorg Med Chem Lett; 2013 Apr; 23(7):2061-4. PubMed ID: 23481651
[TBL] [Abstract][Full Text] [Related]
2. Sources of heterogeneous contrast enhancement in the gastrointestinal tract.
Wan X; Wedeking P; Tweedle MF
Magn Reson Imaging; 1994; 12(7):1009-12. PubMed ID: 7997087
[TBL] [Abstract][Full Text] [Related]
3. A neutral polydisulfide containing Gd(III) DOTA monoamide as a redox-sensitive biodegradable macromolecular MRI contrast agent.
Ye Z; Zhou Z; Ayat N; Wu X; Jin E; Shi X; Lu ZR
Contrast Media Mol Imaging; 2016; 11(1):32-40. PubMed ID: 26218648
[TBL] [Abstract][Full Text] [Related]
4. Ultrasmall graphene oxide based T
Zhang M; Liu X; Huang J; Wang L; Shen H; Luo Y; Li Z; Zhang H; Deng Z; Zhang Z
Nanomedicine; 2018 Oct; 14(7):2475-2483. PubMed ID: 28552648
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and evaluation of a targeted nanoglobular dual-modal imaging agent for MR imaging and image-guided surgery of prostate cancer.
Tan M; Ye Z; Lindner D; Brady-Kalnay SM; Lu ZR
Pharm Res; 2014 Jun; 31(6):1469-76. PubMed ID: 23471641
[TBL] [Abstract][Full Text] [Related]
6. The interplay of T1- and T2-relaxation on T1-weighted MRI of hMSCs induced by Gd-DOTA-peptides.
Cao L; Li B; Yi P; Zhang H; Dai J; Tan B; Deng Z
Biomaterials; 2014 Apr; 35(13):4168-74. PubMed ID: 24560458
[TBL] [Abstract][Full Text] [Related]
7. Sequential fast 3D MRI following oral ingestion of Gd-DOTA: A new means to assess intestinal transit time.
Patak MA; Weishaupt D; Fröhlich JM; Debatin JF
J Magn Reson Imaging; 1999 Sep; 10(3):474-6. PubMed ID: 10508311
[TBL] [Abstract][Full Text] [Related]
8. Gd-DOTA loaded into red blood cells, a new magnetic resonance imaging contrast agents for vascular system.
Kravtzoff R; Urvoase E; Chambon C; Ropars C
Adv Exp Med Biol; 1992; 326():347-54. PubMed ID: 1295322
[No Abstract] [Full Text] [Related]
9. Design of a Gd-DOTA-phthalocyanine conjugate combining MRI contrast imaging and photosensitization properties as a potential molecular theranostic.
Aydın Tekdaş D; Garifullin R; Şentürk B; Zorlu Y; Gundogdu U; Atalar E; Tekinay AB; Chernonosov AA; Yerli Y; Dumoulin F; Guler MO; Ahsen V; Gürek AG
Photochem Photobiol; 2014; 90(6):1376-86. PubMed ID: 25131633
[TBL] [Abstract][Full Text] [Related]
10. Gadolinium-Labeled Aminoglycoside and Its Potential Application as a Bacteria-Targeting Magnetic Resonance Imaging Contrast Agent.
Zhang L; Liu Y; Zhang Q; Li T; Yang M; Yao Q; Xie X; Hu HY
Anal Chem; 2018 Feb; 90(3):1934-1940. PubMed ID: 29293308
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and relaxivity studies of a DOTA-based nanomolecular chelator assembly supported by an icosahedral closo-B₁₂²⁻ core for MRI: a click chemistry approach.
Goswami LN; Ma L; Kueffer PJ; Jalisatgi SS; Hawthorne MF
Molecules; 2013 Jul; 18(8):9034-48. PubMed ID: 23899836
[TBL] [Abstract][Full Text] [Related]
12. Gd-DOTA conjugate of RGD as a potential tumor-targeting MRI contrast agent.
Park JA; Lee JJ; Jung JC; Yu DY; Oh C; Ha S; Kim TJ; Chang Y
Chembiochem; 2008 Nov; 9(17):2811-3. PubMed ID: 18956393
[No Abstract] [Full Text] [Related]
13. Imaging of Human Insulin Secreting Cells with Gd-DOTA-P88, a Paramagnetic Contrast Agent Targeting the Beta Cell Biomarker FXYD2γa.
Demine S; Balhuizen A; Debaille V; Joosten L; Fereau M; Chilla SNM; Millard I; Scharfmann R; Egrise D; Goldman S; Marchetti P; Gotthardt M; Laurent S; Burtea C; Eizirik DL
Molecules; 2018 Aug; 23(9):. PubMed ID: 30134599
[TBL] [Abstract][Full Text] [Related]
14. Comparison of iron oxide particles (AMI 227) with a gadolinium complex (Gd-DOTA) in dynamic susceptibility contrast MR imagings (FLASH and EPI) for both phantom and rat brain at 1.5 Tesla.
Loubeyre P; De Jaegere T; Bosmans H; Miao Y; Ni Y; Landuyt W; Marchal G
J Magn Reson Imaging; 1999 Mar; 9(3):447-53. PubMed ID: 10194716
[TBL] [Abstract][Full Text] [Related]
15. An intravascular MRI contrast agent based on Gd(DO3A-Lys) for tumor angiography.
Yang CT; Chandrasekharan P; He T; Poh Z; Raju A; Chuang KH; Robins EG
Biomaterials; 2014 Jan; 35(1):327-36. PubMed ID: 24138829
[TBL] [Abstract][Full Text] [Related]
16. Gadolinium-1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid conjugate of arabinogalactan as a potential liver-targeting magnetic resonance imaging contrast agent.
Xiao Y; Xue R; You T; Li X; Pei F; Wang X; Lei H
Carbohydr Res; 2014 Aug; 395():9-14. PubMed ID: 24995911
[TBL] [Abstract][Full Text] [Related]
17. [Artificial contrasting during magnetic resonance tomography].
Sergeev PV; Panov OV; Egorova SV; Bolotova EN; Shimanovskii NL; Akhadov TA; Sviridov NK
Vestn Rentgenol Radiol; 1997; (1):45-52. PubMed ID: 9133071
[No Abstract] [Full Text] [Related]
18. Dynamic Contrast-Enhanced MRI Using a Macromolecular MR Contrast Agent (P792): Evaluation of Antivascular Drug Effect in a Rabbit VX2 Liver Tumor Model.
Park HS; Han JK; Lee JM; Kim YI; Woo S; Yoon JH; Choi JY; Choi BI
Korean J Radiol; 2015; 16(5):1029-37. PubMed ID: 26357497
[TBL] [Abstract][Full Text] [Related]
19. Naphthalene-facilitated self-assembly of a Gd-chelate as a novel
Zhang Y; Zhang H; Huang D; Tan B; Zhang C; Deng Z
J Mater Chem B; 2021 Jul; 9(28):5729-5737. PubMed ID: 34231635
[TBL] [Abstract][Full Text] [Related]
20. Size-stable solid lipid nanoparticles loaded with Gd-DOTA for magnetic resonance imaging.
Andreozzi E; Wang P; Valenzuela A; Tu C; Gorin F; Dhenain M; Louie A
Bioconjug Chem; 2013 Sep; 24(9):1455-67. PubMed ID: 24004269
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
